Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice
暂无分享,去创建一个
J. Jais | C. Schreiweis | S. Moriceau | P. Zielenkiewicz | D. Vidovic | I. Sermet-Gaudelus | A. Edelman | C. Gravier-Pelletier | A. Hinzpeter | R. Freund | I. Pranke | F. Oury | G. Prestat | M. F. da Cunha | A. Sassi | A. Hatton | Norbert Odolczyk | Geordie Creste | F. Berhal | M. S. Carlon | Vincent Jullien
[1] J. Mornon,et al. New insights into structure and function of bis-phosphinic acid derivatives and implications for CFTR modulation , 2021, Scientific Reports.
[2] L. Ostrowski,et al. Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia. , 2020, American journal of respiratory and critical care medicine.
[3] L. Lands,et al. Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele. , 2019, The New England journal of medicine.
[4] A. Orth,et al. Structure-guided combination therapy to potently improve the function of mutant CFTRs , 2018, Nature Medicine.
[5] Aviv Regev,et al. A revised airway epithelial hierarchy includes CFTR-expressing ionocytes , 2018, Nature.
[6] S. Rowe,et al. The therapeutic potential of CFTR modulators for COPD and other airway diseases , 2017, Current opinion in pharmacology.
[7] J. Jais,et al. Analysis of nasal potential in murine cystic fibrosis models. , 2016, The international journal of biochemistry & cell biology.
[8] K. Zatloukal,et al. Genetic deletion of keratin 8 corrects the altered bone formation and osteopenia in a mouse model of cystic fibrosis. , 2016, Human molecular genetics.
[9] V. Baekelandt,et al. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice. , 2016, American journal of respiratory and critical care medicine.
[10] I. Sermet-Gaudelus,et al. Biosynthesis of cystic fibrosis transmembrane conductance regulator. , 2014, The international journal of biochemistry & cell biology.
[11] Piotr Zielenkiewicz,et al. Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain , 2013, EMBO molecular medicine.
[12] G. Lukács,et al. Mechanism-based corrector combination restores ΔF508-CFTR folding and function , 2013, Nature Chemical Biology.
[13] F. Ratjen,et al. Early lung disease in cystic fibrosis. , 2013, The Lancet. Respiratory medicine.
[14] I. Sermet-Gaudelus,et al. Characterization of Nasal Potential Difference in cftr Knockout and F508del-CFTR Mice , 2013, PloS one.
[15] G. Lukács,et al. Disruption of cytokeratin-8 interaction with F508del-CFTR corrects its functional defect. , 2012, Human molecular genetics.
[16] L. Touqui,et al. Mouse models of cystic fibrosis: phenotypic analysis and research applications. , 2011, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[17] P. Lebecque,et al. Airway delivery of low-dose miglustat normalizes nasal potential difference in F508del cystic fibrosis mice. , 2009, American journal of respiratory and critical care medicine.
[18] P. Lebecque,et al. Preclinical evidence that sildenafil and vardenafil activate chloride transport in cystic fibrosis. , 2008, American journal of respiratory and critical care medicine.
[19] M. Welsh,et al. Processing and function of CFTR-ΔF508 are species-dependent , 2007, Proceedings of the National Academy of Sciences.
[20] M. Welsh,et al. Processing and function of CFTR-DeltaF508 are species-dependent. , 2007, Proceedings of the National Academy of Sciences of the United States of America.
[21] A. Edelman,et al. Rescue of ΔF508-CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) by Curcumin: Involvement of the Keratin 18 Network , 2006, Journal of Pharmacology and Experimental Therapeutics.
[22] Paola Vergani,et al. The ABC protein turned chloride channel whose failure causes cystic fibrosis , 2006, Nature.
[23] A. Edelman,et al. involvement of the keratin 18 network. , 2006 .
[24] H. Ye,et al. Distribution of ion transport mRNAs throughout murine nose and lung. , 2000, American journal of physiology. Lung cellular and molecular physiology.
[25] H. Morreau,et al. A mouse model for the cystic fibrosis delta F508 mutation. , 1995, The EMBO journal.
[26] H. S. Kim,et al. Toward an animal model of cystic fibrosis: targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[27] J. Gustafson,et al. Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.